MX9306220A - Ptp 1d: una proteina tirosina fosfatasa novedosa. - Google Patents
Ptp 1d: una proteina tirosina fosfatasa novedosa.Info
- Publication number
- MX9306220A MX9306220A MX9306220A MX9306220A MX9306220A MX 9306220 A MX9306220 A MX 9306220A MX 9306220 A MX9306220 A MX 9306220A MX 9306220 A MX9306220 A MX 9306220A MX 9306220 A MX9306220 A MX 9306220A
- Authority
- MX
- Mexico
- Prior art keywords
- ptp
- protein
- novyose
- phosphatase protein
- presented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La proteína nombrada PTP ID es una proteína tirosina fosfatasa novedosa. La proteína PTP ID puede ser producida por medios recombinantes , por ejemplo empleando una estructura de ácido nucléico que codifica la proteína como se proporciona en la presente. Se presenta también un anticuerpo especifico para un epítopo de la proteína PTP ID. Se presenta también métodos para identificar compuestos que se enlazan a una proteína PTP ID e inhiben o estimulan su actividad enzimática, composiciones farmacéuticas que comprenden PTP ID, así como métodos para tratar una enfermedad asociada con la proteína PTP ID mediante el uso de tales composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95631592A | 1992-10-06 | 1992-10-06 | |
US08/018,129 US5589375A (en) | 1992-10-06 | 1993-02-16 | PTP 1D: a novel protein tyrosine phosphatase |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9306220A true MX9306220A (es) | 1994-05-31 |
Family
ID=26690776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9306220A MX9306220A (es) | 1992-10-06 | 1993-10-06 | Ptp 1d: una proteina tirosina fosfatasa novedosa. |
Country Status (8)
Country | Link |
---|---|
US (3) | US5589375A (es) |
EP (1) | EP0663954A1 (es) |
JP (1) | JPH08502885A (es) |
CN (1) | CN1091469A (es) |
AU (1) | AU5175793A (es) |
CA (1) | CA2146544A1 (es) |
MX (1) | MX9306220A (es) |
WO (1) | WO1994008017A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0687307A4 (en) * | 1993-02-18 | 1997-11-26 | Univ Massachusetts Medical | INHIBITION OF TAX PROTEIN-INDUCED DNA BINDING INCREASE |
US6184205B1 (en) * | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
US6166292A (en) * | 1996-04-26 | 2000-12-26 | Ajinomoto Co., Inc. | Raffinose synthetase gene, method of producing raffinose and transgenic plant |
US6891084B1 (en) | 1996-04-26 | 2005-05-10 | Ajinomoto Co., Inc. | DNA encoding raffinose synthase from soybean |
US5912138A (en) * | 1996-07-25 | 1999-06-15 | Cold Spring Harbor Laboratory | Substrate trapping protein tyrosine phosphatases |
US6004791A (en) * | 1996-11-13 | 1999-12-21 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Protein tyrosine phosphatase PTP20 and related products and methods |
WO1999023493A1 (en) * | 1997-10-31 | 1999-05-14 | The Rockefeller University | Methods of identifying agents that modulate leptin activity |
US6156551A (en) * | 1998-06-05 | 2000-12-05 | Beth Israel Deaconess Medical Center | Activated mutants of SH2-domain-containing protein tyrosine phosphatases and methods of use thereof |
US6355786B1 (en) | 1998-10-30 | 2002-03-12 | Vanderbilt University | Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same |
US6200807B1 (en) | 1999-07-21 | 2001-03-13 | Isis Pharmaceuticals Inc. | Antisense inhibition of SHP-2 expression |
US7018810B1 (en) * | 1999-12-07 | 2006-03-28 | Amgen Inc. | Chordin-like molecules and uses thereof |
CN1320699A (zh) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | 一种新的多肽——人磷脂酶9和编码这种多肽的多核苷酸 |
US6897061B1 (en) | 2000-06-16 | 2005-05-24 | Spinal Cord Society | Transdifferentiation of glial cells |
CN1329020A (zh) * | 2000-06-21 | 2002-01-02 | 上海博德基因开发有限公司 | 一种新的多肽——酸性磷酸酶家族蛋白11和编码这种多肽的多核苷酸 |
AU2001270252B2 (en) * | 2000-07-03 | 2007-02-08 | Catalent Pharma Solutions, Llc | Expression vectors |
AU2001271614B2 (en) * | 2000-07-03 | 2007-05-31 | Catalent Pharma Solutions, Llc | Host cells containing multiple integrating vectors |
US20030224415A1 (en) * | 2001-06-29 | 2003-12-04 | Gala Design, Inc. | Selection free growth of host cells containing multiple integrating vectors |
US7105328B2 (en) | 2001-04-02 | 2006-09-12 | Dana-Farber Cancer Institute | Methods for screening for compounds that modulate pd-1 signaling |
AU2002334773A1 (en) * | 2001-10-01 | 2003-04-14 | Mount Sinai School Of Medicine | Noonan syndrome gene |
US20050069549A1 (en) | 2002-01-14 | 2005-03-31 | William Herman | Targeted ligands |
US20040038304A1 (en) * | 2002-03-28 | 2004-02-26 | Gala Design, Inc. | Antibody libraries |
US7384738B2 (en) * | 2002-03-28 | 2008-06-10 | Bremel Robert D | Retrovirus-based genomic screening |
EP1523567A1 (en) * | 2002-07-18 | 2005-04-20 | Structural Genomix, Inc. | Methods of enhancing yields of soluble proteins |
US20050221429A1 (en) * | 2004-01-16 | 2005-10-06 | Cardinal Health Pts, Llc | Host cells containing multiple integrating vectors comprising an amplifiable marker |
US9114148B2 (en) * | 2004-09-09 | 2015-08-25 | University Of Cincinnati | Modulating phosphatase activity in cardiac cells |
WO2006071451A2 (en) * | 2004-12-03 | 2006-07-06 | The Regents Of The University Of California | Compounds that prevent macrophage apoptosis and uses thereof |
WO2014022759A1 (en) | 2012-08-03 | 2014-02-06 | Dana-Farber Cancer Institute, Inc. | Agents that modulate immune cell activation and methods of use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675285A (en) * | 1984-09-19 | 1987-06-23 | Genetics Institute, Inc. | Method for identification and isolation of DNA encoding a desired protein |
JPH05508777A (ja) * | 1990-07-11 | 1993-12-09 | ニューヨーク ユニバーシティー | 新規なレセプター型ホスホチロシンホスファターゼ |
US5536636A (en) * | 1991-06-26 | 1996-07-16 | Beth Israel Hospital | Methods for identifying a tyrosine phosphatase abnormality associated with neoplastic disease |
-
1993
- 1993-02-16 US US08/018,129 patent/US5589375A/en not_active Expired - Fee Related
- 1993-10-06 CA CA002146544A patent/CA2146544A1/en not_active Abandoned
- 1993-10-06 JP JP6508729A patent/JPH08502885A/ja active Pending
- 1993-10-06 WO PCT/EP1993/002728 patent/WO1994008017A1/en not_active Application Discontinuation
- 1993-10-06 AU AU51757/93A patent/AU5175793A/en not_active Abandoned
- 1993-10-06 MX MX9306220A patent/MX9306220A/es unknown
- 1993-10-06 EP EP93922911A patent/EP0663954A1/en not_active Ceased
- 1993-10-06 CN CN93114840A patent/CN1091469A/zh active Pending
-
1995
- 1995-05-23 US US08/448,250 patent/US5981251A/en not_active Expired - Fee Related
-
1999
- 1999-03-31 US US09/282,257 patent/US6548641B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08502885A (ja) | 1996-04-02 |
US5589375A (en) | 1996-12-31 |
US5981251A (en) | 1999-11-09 |
WO1994008017A1 (en) | 1994-04-14 |
CA2146544A1 (en) | 1994-04-14 |
AU5175793A (en) | 1994-04-26 |
US6548641B1 (en) | 2003-04-15 |
EP0663954A1 (en) | 1995-07-26 |
CN1091469A (zh) | 1994-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9306220A (es) | Ptp 1d: una proteina tirosina fosfatasa novedosa. | |
ES2074042T3 (es) | Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores. | |
PT804236E (pt) | Utilizacao de anticorpos anti-tnf como medicamento para tratamento de doencas que envolvem um elevado nivel serico de interleucina-6 | |
BR9714517A (pt) | Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
AR027060A1 (es) | Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos, asi como el uso deestos compuestos para la fabricacion de medicamentos | |
AR002705A1 (es) | Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen. | |
ES2098140T3 (es) | Liosferas que contienen gonadotropina. | |
ES2125901T3 (es) | Empleo de lipasas para la obtencion de medicamentos. | |
ES2118058T3 (es) | Factor de crecimiento de las celulas t. | |
SV1998000139A (es) | Procedimiento para la preparacion de acidos 8-metoxi-quinoloncarboxilicos ref.lea 32634-sv | |
AR017887A1 (es) | Estructuras artificiales de acidos nucleicos, procedimiento para su preparacion, celula aislada y uso de dichas estructuras y dicha celula para lamanufactura de un medicamento | |
CO5050328A1 (es) | Sistema solvente para la mejor penetracion de compuestos farmaceuticos | |
EP0214620A3 (en) | Transdermal application form of calcium antagonists | |
AR029624A1 (es) | Anticuerpos o fragmentos de anticuerpos anti-idiotipicos recombinantes y composicion farmaceutica que los contiene | |
DE69010294D1 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
ES2077674T3 (es) | Aumento de la produccion de proteinas en animales. | |
ES2074983T3 (es) | Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales. | |
DK450086A (da) | 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse | |
ES2026485T3 (es) | Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas. | |
ES2056876T3 (es) | Compuestos piperidinilicos 1,4-disustituidos. | |
UY26507A1 (es) | Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparación, medicamentos que contienen estos compuestos, así como el uso de estos compuestos para la preparación de medicamentos | |
DE3751602D1 (de) | Subkutane Verabreichung des humanen Choriongonadotropins. | |
AU5198686A (en) | Praparat zur intramuskularen injektion von medikamenten vitaminen oder impfstoffen |